Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-first microcap is using its balance sheet to accumulate BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Mural Oncology PLC MURA

Healthcare Biotechnology
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company’s lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat... see more

Recent & Breaking News (NDAQ:MURA)

Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition

GlobeNewswire December 5, 2025

Mural Oncology Announces Sanction of the Scheme by the High Court

GlobeNewswire December 3, 2025

Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

GlobeNewswire November 26, 2025

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

GlobeNewswire October 24, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders

PR Newswire September 29, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Reminds Shareholders of Upcoming Merger Deadlines - AMWD, PHLT, ARIS, and MURA

GlobeNewswire September 28, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - AMWD, PHLT, ARIS, and MURA

PR Newswire September 27, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders

GlobeNewswire September 27, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - AMWD, PHLT, ARIS, and MURA

GlobeNewswire September 26, 2025

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

GlobeNewswire September 23, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

GlobeNewswire September 23, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - GTLS, PHLT, ARIS, and MURA

GlobeNewswire September 23, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBAN, HBI, NWE, MURA on Behalf of Shareholders

PR Newswire September 23, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - GTLS, PHLT, ARIS, and MURA

PR Newswire September 22, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders

GlobeNewswire September 11, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - NWE, GES, MURA, and TZUP

GlobeNewswire September 11, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, BKH, MURA, SCPH on Behalf of Shareholders

PR Newswire August 28, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Mural Oncology plc (NASDAQ: MURA)

PR Newswire August 27, 2025

MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders

Business Wire August 20, 2025

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

GlobeNewswire August 20, 2025

Podcasts